UniProt ID | T2EA_HUMAN | |
---|---|---|
UniProt AC | P29083 | |
Protein Name | General transcription factor IIE subunit 1 | |
Gene Name | GTF2E1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 439 | |
Subcellular Localization | Nucleus. | |
Protein Description | Recruits TFIIH to the initiation complex and stimulates the RNA polymerase II C-terminal domain kinase and DNA-dependent ATPase activities of TFIIH. Both TFIIH and TFIIE are required for promoter clearance by RNA polymerase.. | |
Protein Sequence | MADPDVLTEVPAALKRLAKYVIRGFYGIEHALALDILIRNSCVKEEDMLELLKFDRKQLRSVLNNLKGDKFIKCRMRVETAADGKTTRHNYYFINYRTLVNVVKYKLDHMRRRIETDERDSTNRASFKCPVCSSTFTDLEANQLFDPMTGTFRCTFCHTEVEEDESAMPKKDARTLLARFNEQIEPIYALLRETEDVNLAYEILEPEPTEIPALKQSKDHAATTAGAASLAGGHHREAWATKGPSYEDLYTQNVVINMDDQEDLHRASLEGKSAKERPIWLRESTVQGAYGSEDMKEGGIDMDAFQEREEGHAGPDDNEEVMRALLIHEKKTSSAMAGSVGAAAPVTAANGSDSESETSESDDDSPPRPAAVAVHKREEDEEEDDEFEEVADDPIVMVAGRPFSYSEVSQRPELVAQMTPEEKEAYIAMGQRMFEDLFE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADPDVLTE ------CCCHHHHHH | 36.72 | 22814378 | |
8 | Phosphorylation | MADPDVLTEVPAALK CCCHHHHHHHHHHHH | 34.48 | 21406692 | |
15 | Ubiquitination | TEVPAALKRLAKYVI HHHHHHHHHHHHHHH | 40.41 | 24816145 | |
15 | 2-Hydroxyisobutyrylation | TEVPAALKRLAKYVI HHHHHHHHHHHHHHH | 40.41 | - | |
19 | Acetylation | AALKRLAKYVIRGFY HHHHHHHHHHHHHHC | 44.64 | 25953088 | |
19 | Methylation | AALKRLAKYVIRGFY HHHHHHHHHHHHHHC | 44.64 | - | |
44 | Acetylation | LIRNSCVKEEDMLEL HHHCCCCCHHHHHHH | 60.76 | 26051181 | |
67 | Acetylation | RSVLNNLKGDKFIKC HHHHHHCCCCCEEEE | 68.16 | 19608861 | |
67 | Ubiquitination | RSVLNNLKGDKFIKC HHHHHHCCCCCEEEE | 68.16 | 33845483 | |
67 | Malonylation | RSVLNNLKGDKFIKC HHHHHHCCCCCEEEE | 68.16 | 26320211 | |
70 | Acetylation | LNNLKGDKFIKCRMR HHHCCCCCEEEEEEE | 58.62 | 25953088 | |
73 | Ubiquitination | LKGDKFIKCRMRVET CCCCCEEEEEEEEEE | 20.94 | 24816145 | |
80 | Phosphorylation | KCRMRVETAADGKTT EEEEEEEECCCCCCE | 25.04 | - | |
85 | Acetylation | VETAADGKTTRHNYY EEECCCCCCEECCEE | 47.47 | 19817303 | |
85 | Ubiquitination | VETAADGKTTRHNYY EEECCCCCCEECCEE | 47.47 | 24816145 | |
86 | Phosphorylation | ETAADGKTTRHNYYF EECCCCCCEECCEEE | 34.29 | 29083192 | |
87 | Phosphorylation | TAADGKTTRHNYYFI ECCCCCCEECCEEEE | 33.16 | 29083192 | |
91 | Phosphorylation | GKTTRHNYYFINYRT CCCEECCEEEEEHHH | 8.14 | 20090780 | |
92 | Phosphorylation | KTTRHNYYFINYRTL CCEECCEEEEEHHHH | 11.87 | 22817900 | |
98 | Phosphorylation | YYFINYRTLVNVVKY EEEEEHHHHHHHHHH | 25.38 | 20068231 | |
104 | Ubiquitination | RTLVNVVKYKLDHMR HHHHHHHHHHHHHHH | 32.17 | - | |
105 | Phosphorylation | TLVNVVKYKLDHMRR HHHHHHHHHHHHHHH | 12.74 | 20068231 | |
126 | Phosphorylation | RDSTNRASFKCPVCS CCCCCCCCCCCCCCC | 23.23 | 24719451 | |
188 | Phosphorylation | NEQIEPIYALLRETE HHHHHHHHHHHHHCC | 11.25 | 21945579 | |
201 | Phosphorylation | TEDVNLAYEILEPEP CCCCCHHHHHHCCCC | 13.48 | 28796482 | |
218 | Ubiquitination | IPALKQSKDHAATTA CCCHHCCCCCHHHHH | 51.55 | 29967540 | |
229 | Phosphorylation | ATTAGAASLAGGHHR HHHHHHHHHHCCCCH | 20.44 | 28555341 | |
245 | Phosphorylation | AWATKGPSYEDLYTQ HHCCCCCCHHHHHCC | 50.23 | 29978859 | |
246 | Phosphorylation | WATKGPSYEDLYTQN HCCCCCCHHHHHCCC | 19.32 | 29978859 | |
250 | Phosphorylation | GPSYEDLYTQNVVIN CCCHHHHHCCCEEEE | 20.71 | 29978859 | |
251 | Phosphorylation | PSYEDLYTQNVVINM CCHHHHHCCCEEEEC | 22.44 | 27642862 | |
268 | Phosphorylation | QEDLHRASLEGKSAK HHHHHHHHHCCCCCC | 27.23 | 25159151 | |
272 | Ubiquitination | HRASLEGKSAKERPI HHHHHCCCCCCCCCC | 37.55 | 29967540 | |
284 | Phosphorylation | RPIWLRESTVQGAYG CCCEEEECCCCCCCC | 27.69 | 22210691 | |
285 | Phosphorylation | PIWLRESTVQGAYGS CCEEEECCCCCCCCC | 16.46 | 27251275 | |
290 | Phosphorylation | ESTVQGAYGSEDMKE ECCCCCCCCCHHHHH | 28.19 | 27732954 | |
292 | Phosphorylation | TVQGAYGSEDMKEGG CCCCCCCCHHHHHCC | 20.11 | 21815630 | |
296 | Ubiquitination | AYGSEDMKEGGIDMD CCCCHHHHHCCCCHH | 66.58 | 24816145 | |
330 | Acetylation | RALLIHEKKTSSAMA HHHHHHCCCCCCCCC | 47.38 | 25953088 | |
330 | Ubiquitination | RALLIHEKKTSSAMA HHHHHHCCCCCCCCC | 47.38 | 33845483 | |
332 | Phosphorylation | LLIHEKKTSSAMAGS HHHHCCCCCCCCCCC | 38.69 | 26074081 | |
333 | Phosphorylation | LIHEKKTSSAMAGSV HHHCCCCCCCCCCCC | 25.61 | 26074081 | |
334 | Phosphorylation | IHEKKTSSAMAGSVG HHCCCCCCCCCCCCC | 27.56 | 26074081 | |
339 | Phosphorylation | TSSAMAGSVGAAAPV CCCCCCCCCCCCCCE | 14.08 | 26074081 | |
347 | Phosphorylation | VGAAAPVTAANGSDS CCCCCCEEECCCCCC | 20.99 | 26074081 | |
352 | Phosphorylation | PVTAANGSDSESETS CEEECCCCCCCCCCC | 37.46 | 26074081 | |
354 | Phosphorylation | TAANGSDSESETSES EECCCCCCCCCCCCC | 44.73 | 26074081 | |
356 | Phosphorylation | ANGSDSESETSESDD CCCCCCCCCCCCCCC | 50.56 | 26074081 | |
358 | Phosphorylation | GSDSESETSESDDDS CCCCCCCCCCCCCCC | 47.26 | 21406692 | |
359 | Phosphorylation | SDSESETSESDDDSP CCCCCCCCCCCCCCC | 30.93 | 22210691 | |
361 | Phosphorylation | SESETSESDDDSPPR CCCCCCCCCCCCCCC | 46.21 | 21406692 | |
365 | Phosphorylation | TSESDDDSPPRPAAV CCCCCCCCCCCCCEE | 43.74 | 21406692 | |
419 | Phosphorylation | PELVAQMTPEEKEAY HHHHHCCCHHHHHHH | 18.57 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of T2EA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of T2EA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of T2EA_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-67, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND MASSSPECTROMETRY. |